Food Safety Testing Market to Grow by USD 8.11 billion The increase in the involvement of government agencies drives the market growth - Technavio
NEOG Stock | USD 12.14 0.19 1.54% |
Roughly 63% of all Neogen's stockholders are looking to take a long position. The analysis of overall sentiment of trading Neogen stock suggests that some investors are interested at this time. The current market sentiment, together with Neogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Neogen stock news signals to limit their universe of possible portfolio assets.
Neogen |
The food safety testing market size is expected to grow by USD 8.11 bn from 2021 to 2026. The growth momentum of the market will accelerate at a CAGR of 7.69 percent during the forecast period. The increase in the involvement of government agencies is driving the growth of the food safety testing market. However, factors such as lack of infrastructure and underutilization of resources in developing countries challenge the market growth. For more information about the drivers, challenges, and trends imp
Read at finance.yahoo.com
Neogen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Neogen Fundamental Analysis
We analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Neogen is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Neogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neogen stock to make a market-neutral strategy. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics with similar companies.
Peers
Neogen Related Equities
SHC | Sotera Health | 2.40 | ||||
FONR | Fonar | 1.07 | ||||
MYGN | Myriad Genetics | 0.59 | ||||
ICLR | ICON PLC | 0.03 | ||||
MEDP | Medpace Holdings | 0.33 | ||||
QGEN | Qiagen NV | 0.40 | ||||
IQV | IQVIA Holdings | 0.48 | ||||
RDNT | RadNet | 1.66 | ||||
SERA | Sera Prognostics | 2.40 | ||||
BNR | Burning Rock | 2.88 | ||||
XGN | Exagen | 4.21 | ||||
ACRS | Aclaris Therapeutics | 9.16 |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |